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Abstract 
Bacteria can switch between planktonic forms (single cells) and biofilms, i.e., bacterial 
communities growing on solid surfaces and embedded in a matrix of extracellular polymeric 
substance. Biofilm formation by pathogenic bacteria often results in lower susceptibility to 
antibiotic treatments and in development of chronic infections; thus, biofilm formation can be 
considered an important virulence factor. In recent years, much attention has been directed towards 
understanding the biology of biofilms and towards searching for inhibitors of biofilm development 
and of biofilm-related cellular processes. In this report, we review selected examples of target-based 
screening for anti-biofilm agents: we focus on inhibitors of quorum sensing, possibly the most 
characterized target for molecules with anti-biofilm activity, and on compounds interfering with the 
metabolism of the signal molecule cyclic di-GMP metabolism and on inhibitors of DNA and 
nucleotide biosynthesis, which represent a novel and promising class of biofilm inhibitors. Finally, 
we discuss the activation of biofilm dispersal as a novel mode of action for anti-biofilm compounds.  
 
Introduction 
Bacteria are able to switch between two different “lifestyles”: single cells (planktonic mode) 
and biofilms. A biofilm is defined as a sessile microbial community characterized by adhesion to a 
solid surface and by production of a matrix, which surrounds the bacterial cells and include 
extracellular polysaccharides (EPS), proteins and DNA. Transition from planktonic cells to biofilm 
is regulated by a variety of environmental and physiological cues, such as bacterial cell density, 
nutrient availability and cellular stress. A detailed discussion of biofilm-related cellular processes 
and of their molecular mechanisms goes beyond the aim of this mini-review: extensive descriptions 
of the biology of biofilm development can be found in excellent reviews devoted to this subject 
(Miller and Bassler, 2001; Tamayo et al., 2007; Karatan and Watnick, 2009).  
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Biofilm and planktonic cells differ significantly in their physiology, gene expression pattern 
and even morphology. Bacteria growing in biofilms are less sensitive to treatments with 
antimicrobial agents compared to planktonic cells (Costerton et al. 1995; Anderl et al. 2000; Ceri et 
al. 2001). Although the molecular mechanisms of tolerance to antibiotics are not yet fully 
understood, it has been proposed that the extracellular matrix can affect penetration of antibiotics 
into bacterial cells. In addition, a dormant metabolic state of a fraction of biofilm cells would also 
contribute to their decreased antibiotic sensitivity (reviewed in Lewis 2008). Interestingly, exposure 
to subinhibitory concentrations of antibiotics can itself act as an environmental signal triggering 
biofilm formation (Hoffman et al. 2005; Anderson and O’ Toole 2008; Nucleo et al. 2009). Since 
pathogenic bacteria are normally exposed to subinhibitory concentrations of antibiotics during 
antimicrobial therapy in patients (Odenholt 2001), biofilm formation can therefore be further 
increased by antibiotic treatment, posing a significant problem for the eradication of bacterial 
infections.  
In addition to providing tolerance to antibiotic treatment, biofilms also play an important 
role in virulence of many pathogenic bacteria. For instance, in Pseudomonas aeruginosa, many 
virulence factors are expressed during biofilm formation (Wagner et al., 2004; Wagner et al., 2007). 
In contrast, in other bacteria, such as Staphylococcus aureus, exotoxins and other virulence factors 
are downregulated during biofilm growth (Kong et al., 2006). However, negative regulation of 
virulence factors in bacterial biofilms can also be employed as a strategy for host infection by 
pathogenic bacteria: indeed, biofilm growth results in high numbers of non-virulent biofilm 
dwelling bacteria. When biofilms eventually disperse in a co-ordinated fashion, a large number of 
planktonic bacteria, that quickly become virulent, are released simultaneously (Smith and Iglewski 
2003; Tamayo et al. 2007; Karatan and Watnick 2009). These observations, and the fact that 
bacterial resistance is undermining the efficacy of currently used antibiotics, indicate that there is a 
strong need for novel approaches to target pathogenic bacteria growing in biofilms. Therefore, the 
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cellular processes of biofilm formation, maintenance and dispersal are important targets for the 
discovery of novel chemical inhibitors. These inhibitors may be used either alone or in combination 
with conventional antimicrobial agents in anti-infective therapies. To achieve this goal it is clear 
that a full understanding of the basic biology of these processes is required to drive forward such 
technologies. 
 
Target based screening  
A basic strategy for the discovery of biofilm inhibitors is the direct screening of chemical 
compounds in biofilm formation assays (Junker and Clardy 2007; Richards et al. 2008; Rivardo et 
al. 2009). However, such a direct approach also selects for non-specific biofilm inhibitors such as 
detergents or biosurfactants which are not therapeutically useful. Although these classes of 
molecules can display significant anti-biofilm activity under laboratory conditions, they often show 
limited activity, or lack of selective toxicity towards bacteria, if used in vivo. In recent years, the 
improvement in our understanding of the cellular processes controlling bacterial biofilms has 
allowed the development of target-oriented approaches for the discovery of biofilm inhibitors. 
Development of target-based screening constitutes a rational and effective strategy for discovery of 
biofilm inhibitors. Characterization of quorum sensing as an important regulatory mechanism in 
biofilm formation, and thus as a potential target for antimicrobials (Smith and Iglewski 2003; 
Njoroge and Sperandio 2009), has led to the development of screening strategies for quorum 
sensing inhibitors. In turn, identification of biofilm inhibitors through a target-based approach has 
contributed to the elucidation of cellular processes controlling bacterial biofilms (Figure 1). The 
discovery that several compounds with anti-biofilm activity (e.g., halogenated furanones) are 
quorum sensing inhibitors (Hentzer et al. 2002; Manefield et al. 2002; Bjarnsholt et al. 2005; 
Persson et al. 2005; Rasmussen et al. 2005) confirmed the importance of this signaling system in 
biofilm formation. More recently, the search for novel biofilm inhibitors has selected targets other 
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than quorum sensing, such as nucleotide biosynthesis (Attila et al. 2009, Ueda et al. 2009) and 
production of the signal molecule cyclic di-GMP (c-di-GMP; Antoniani et al. 2010).  
 
Activity based screening for quorum sensing inhibitors 
Quorum sensing (QS) is a complex regulatory process dependent on bacterial cell density 
(Miller and Bassler 2001; Karatan and Watnick 2009) and is typically involved in regulation of 
genes involved in biofilm maturation and maintenance (Hammer and Bassler 2003; Marketon et al. 
2003; Vuong et al. 2003; Ueda and Wood 2009). Indeed, since QS controlled regulatory pathways 
are activated at high bacterial cell density, it is not surprising that QS is induced in biofilms, where 
local cell concentrations can be more than 10-fold higher than planktonic cultures. In addition to its 
role in biofilms, QS can control production of virulence factors in both Gram positive and Gram 
negative pathogenic bacteria (Kong et al. 2006; Xu et al. 2006; Hegde et al. 2009). Thus, inhibitors 
of QS, in addition to possessing antibiofilm activity, could also counteract bacterial pathogenicity. 
During QS signal molecules, or autoinducers, are produced and secreted by the bacterial cells. 
Autoinducer accumulation enables the cell to sense that a sufficient local concentration of bacteria 
(a quorum) has been reached, in order to initiate concerted population responses, including biofilm 
formation. Although regulation by QS is highly conserved in bacteria, its molecular mechanisms, as 
well as the chemical nature of the autoinducers, differ significantly between Gram positive and 
Gram negative bacteria (reviewed in Miller and Bassler 2001; Figure 2). In Gram negative bacteria, 
autoinducers belong to the chemical class of the acyl-homoserine lactones (AHLs; Fuqua et al. 
1996); additional species-specific QS systems make use of other autoinducers, such as 
quinolonones in P. aeruginosa (McKnight et al. 2000), or the Diffusible Signal Factor (DSF), a 
fatty acid (cis-11-methyl-dodecenoic acid) used as signal molecule by the plant pathogen 
Xanthomonas campestris (Barber et al. 1997). AHL autoinducers are synthesized by enzymes of the 
LuxI family and can bind transcription regulators of the LuxR family. AHL binding to LuxR 
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activates the transcription of QS-dependent genes. A scheme summarizing AHL-dependent QS in 
P. aeruginosa is given in Figure 2A.  
In contrast to Gram negative bacteria, the typical quorum sensing signal molecules in Gram 
positive bacteria are short peptides (5-50 amino acids), synthesized by ribosomes and often 
subjected to extensive post-translational modification (Miller and Bassler 2001; Li et al. 2002).
Binding ofsignalling peptides to sensor proteins in the cell membrane triggers a signal transduction 
cascade which leads to phosphorylation of a response regulator and triggers QS-dependent gene 
expression. A model of QS systems in Gram positive bacteria is the agr (accessory gene regulation) 
system of Staphylococcus aureus (Figure 2B), where autoinducer-dependent phosphorylation of the 
AgrA regulator, triggered by biofilm growth, leads to transcription activation of genes encoding 
virulence factors (Novick et al. 1993; Balaban and Novick 1995). The different chemical nature of 
signal molecules and of the molecular mechanisms involved in QS would suggest that QS inhibitors 
can only be directed against either Gram positive or Gram negative bacteria. However, furanones, 
an important class of inhibitors of QS in Gram negative bacteria, also show killing activity against 
Gram positive bacteria and even Protozoa (Lönn-Stensrud et al. 2009; Zhu et al. 2009), suggesting 
that they might target cellular processes other than QS. Indeed, exposure of the Gram positive 
bacterium Bacillus subtilis to furanones triggers induction of stress response genes in a QS-
independent manner (Ren et al. 2004).  
Additional, albeit indirect, evidence for the importance of QS systems based on AHLs in 
various cellular processes of Gram negative bacteria is derived from the fact that both Gram 
positive bacteria and eukaryotic (e.g. plant) cells can produce enzymes, such as lactonases and 
acylases (Dong et al. 2002; Ozer et al. 2005; Park et al. 2005; Uroz and Heinonsalo 2008), able to 
break down these signal molecules. These observations indicate that inhibition of AHL-mediated 
cell-cell communication might confer an advantage in the competition with, or in the defence 
against Gram negative bacterial infection. Search for natural products able to inhibit AHL 
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biosynthesis has led to the identification of halogenated furanones, produced by the marine alga 
Delisea pulchra (Hentzer et al. 2002), and 4-nitro-pyridine-N-oxide (4-NPO) from garlic (Allium 
sativum) cloves (Rasmussen et al 2005). These compounds have been identified using activity-
based screening in which expression of reporter genes under the control of QS-dependent promoters 
was measured (Hentzer et al. 2002; Rasmussen et al. 2005). Further investigation of their 
mechanism of action showed that furanones bind LasR (one of the regulatory proteins responding to 
AHLs in P. aeruginosa) and act as competitive inhibitors of AHL binding. (Hentzer et al 2002). 
Binding of furanones results in faster degradation of LasR, probably due to destabilization of its 
conformation (Manefield et al. 2002), thus leading to complete inhibition of QS-dependent gene 
regulation (Hentzer et al. 2003). Both furanones and 4-NPO inhibit biofilm formation while not 
affecting cell growth, reduce P. aeruginosa virulence in experimental infection models and increase 
its sensitivity to antibiotics (Hentzer et al. 2003). These results demonstrate the effectiveness of 
using QS inhibitors in combination with antibiotics, in order to enhance their bactericidal effect. 
Utilization of an antibiotic plus QS inhibitor combination therapy might also prevent the antibiotic-
dependent induction of biofilm formation observed in different pathogens (Hoffman et al. 2005; 
Gotoh et al. 2008; Nucleo et al. 2009). Unfortunately, toxic and carcinogenic effects as well as poor 
stability in aqueous solutions have greatly limited the utilization of halogenated furanones as 
antimicrobials (Hentzer and Givskov 2003). 
An interesting case of molecules combining antibiotic and anti-biofilm activities is the 
macrolide antibiotics, in particular azithromycin. This antibiotic shows very poor antimicrobial 
activity against P. aeruginosa and other Gram negative bacteria, in particular clinical isolates 
(Hoffmann et al. 2007). However, azithromycin interferes with P. aeruginosa biofilm formation 
(Mizukane et al. 1994; Ichimiya et al. 1996) by blocking AHL-mediated QS (Tateda et al. 2001; 
Nalca et al. 2006). Treatment with azithromycin can attenuate chronic P. aeruginosa lung infection 
and significantly reduce bacterial load in the lungs of Cftr-/- mice, an animal infection model 
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mimicking chronic pneumonia in cystic fibrosis patients (Hoffmann et al. 2007). The molecular 
mechanism of QS inhibition by macrolides has not yet been identified, but it seems likely that they 
might only affect QS in an indirect fashion through interaction with their primary target, i.e. the 
ribosome. An even partial inhibition of ribosome function can trigger synthesis of signal molecules 
such as the alarmone ppGpp; this signal molecule is synthesized by the ribosome-associated RelA 
and SpoT proteins in response to sudden stoppage in protein synthesis, which usually reflects 
scarcity in the cellular amino acid pool (Svitil et al. 1993; Cashel et al. 1996). A role for ppGpp in 
biofilm formation has been described in several reports (McLennan et al. 2008; Boehm et al. 2009), 
although its precise function remains elusive so far. Since ppGpp affects the expression of a large 
number of genes in the bacterial cell, it could be possible that macrolide-induced alterations in 
intracellular ppGpp levels might affect expression of QS genes. 
 
Structure based screening for QS inhibitors 
In addition to activity-based assays, an alternative strategy for target-oriented discovery of 
QS inhibitors is represented by structure-based screening of chemical compounds. This strategy 
relies on the availability of a growing number of three-dimensional protein structures either 
predicted by computational biology methods or characterized through biochemical structural 
analysis. Using molecular modelling programs, it is possible to select potential inhibitors targeting 
catalytic domains or key amino acid residues for protein activity using a virtual screening of small 
molecules with known structures and chemical properties (Li et al. 2008; Kiran et al. 2008; Zeng et 
al. 2008; Yang et al. 2009). This structure-based approach constitutes a primary virtual screening 
followed by a secondary activity-based assay using reporter genes controlled by QS-dependent 
promoters. Another important application of structure-based screening is provided by drug design, 
which is not simply the virtual screening of pre-existing molecules, but the tailoring of new, 
Page 8 of 36Applied Microbiology and Biotechnology
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
F
o
r P
eer R
eview



“custom made”, inhibitors based on the structure of a target protein. Proteins involved in QS of 
Gram negative bacteria, in particular the LasR transcriptional regulator of P. aeruginosa, have been 
used as a target in structure-based screening for biofilm inhibitors. This approach has led to the 
identification of several compounds showing significant inhibition of QS in P. aeruginosa (Smith et 
al. 2003; Müh et al. 2006; Geske et al. 2007; Amara et al. 2009); however, the number of inhibitors 
displaying broad anti-biofilm activity remains low, possibly due to yet not identified resistance 
mechanisms or to inability of QS inhibitors to reach their target in biofilms formed by clinical 
isolates. 
In Gram positive bacteria, QS directly regulates biofilm maintenance and dispersal, rather 
than being a factor in its initial formation (Pratten et al. 2001; Yarwood et al. 2004). In addition, QS 
systems of pathogenic Gram positive bacteria, such as the agr regulatory system of S. aureus, play a 
fundamental role in regulation of virulence factors which contributes to pathogenicity of biofilm-
induced infections, and are therefore considered targets of great interest for antimicrobials able to 
interfere with bacterial virulence (Recsei et al. 1986; Janzon and Arvidson 1990; Abdelnour et al. 
1993; Kong et al. 2006; Abraham 2006).  
An interesting mechanism which interferes with biofilm formation in S. aureus involves the 
heptapeptide RIP. This peptide inhibits biofilm formation of S. aureus in vivo (Giacometti et al. 
2003), possibly by blocking the agr-dependent QS system (Balaban et al. 2004). However, the agr 
system might not be RIP primary target, since it has also been reported that inhibition of the agr 
system increases biofilm formation (Vuong et al. 2003). Although the underlying biology remains 
unclear, RIP appears to have an effect on biofilm formation, and as such, its structure is an 
interesting subject for modelling studies aimed at the identification of other biofilm inhibitors. 
Through structure-based virtual screening using RIP as a template, Kiran et al. (2008) identified 
hamamelitannin, a tannic acid derivative from the bark of Hamamelis virginiana (witch hazel). 
Interestingly, bark extracts of H. virginiana are used in natural medicine as astringent and possess 
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weak antibacterial activity (Iauk et al. 2003). Hamamelitannin displayed strong inhibition of QS in 
S. aureus and other Gram positive bacteria. Similar to inhibitors of QS in Gram negative bacteria, 
treatment with hamamelitannin does not result in any detectable growth inhibition of S. aureus, but 
it effectively counteracts S. aureus infection in animal models (Kiran et al. 2008). This work 
represents a clever variation of the structure-based screening approach in which the molecule used 
for modelling studies was not the target of a desired inhibitor, but itself an inhibitor. 
 
Inhibitors of nucleotide biosynthesis and DNA replication as anti-biofilm agents 
Over the last few years, it has become increasingly clear that modified nucleotides, such as 
cyclic-di-guanosine monophosphate (c-di-GMP), play a pivotal role as signal molecules for biofilm 
regulation (Figure 2A). Accumulation of c-di-GMP stimulates production of adhesion factors via a 
variety of different mechanisms, i.e., allosteric activation of protein activity, protein stabilization, or 
regulation of gene expression at the transcriptional and translational levels (Kulasakara et al. 2006; 
Weinhouse et al. 1997; Simm et al. 2004; Weber et al. 2006; Sudarsan et al. 2008). Intracellular 
levels of c-di-GMP are determined by two classes of enzymes with opposite activities: diguanylate 
cyclases (DGCs), which synthesize c-di-GMP, and c-di-GMP-phosphodiesterases (PDEs), that 
hydrolyze it into the inactive di-guanylate phosphate (pGpG) form (reviewed in Tamayo et al. 
2007). Genes involved in c-di-GMP biosynthesis and turnover are conserved in all Eubacteria, 
while absent in animal species (Galperin 2004), thus suggesting that enzymes involved in c-di-GMP 
biosynthesis might be an interesting target for antibiofilm agents. However, while genes encoding 
DGCs and PDEs are present in remarkably high numbers in Gram negative bacteria, they are much 
less abundant in Gram positives (Galperin 2004). Consistent with this large discrepancy, the role of 
c-di-GMP in biofilm formation and maintenance has been well established in Gram negative 
bacteria, while its importance in Gram positive bacteria remains questionable (Holland et al. 2008). 
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Thus, as observed for quorum sensing inhibitors, it appears that promising targets for biofilm 
control might follow a strict divide between Gram positive and Gram negative bacteria. 
Thanks to our knowledge of cellular processes controlled by c-di-GMP-related enzymes and 
to the availability of structural data on at least two different DGCs (PleD from Caulobacter 
crescentus and WspR from P. aeruginosa (Chan et al. 2004; De et al. 2008), target-oriented 
screening for DGC inhibitors can be performed using either structure-based or activity-based 
approaches. Recently, we have described screening assays for inhibitors of c-di-GMP biosynthesis 
that rely on monitoring of the production of curli and cellulose, two important adhesion factors in E. 
coli. Screening of a commercially available chemical library using these assays has demonstrated 
that sulfathiazole, a known antimicrobial, can inhibit c-di-GMP biosynthesis and prevent biofilm 
formation at subinhibitory concentrations (Antoniani et al. 2010). It is possible that reduction of 
intracellular c-di-GMP levels by sulfathiazole depends on inhibition of tetrahydrofolate 
biosynthesis, in turn affecting thymidine intracellular pools and DNA synthesis, rather than being 
mediated by direct binding to DGCs. It has recently been reported that fluorouracil, which blocks 
DNA replication through inhibition of nucleotide biosynthesis, can prevent biofilm formation at 
concentrations not affecting planktonic cell growth (Attila et al. 2009; Ueda et al. 2009). This 
demonstrates that nucleotide biosynthesis inhibitors also show anti-biofilm activity and suggest that 
a decrease in cellular nucleotide pools negatively affects biofilm formation. Consistent with this 
finding, surface adhesion is impaired by mutations in genes responsible for nucleotide biosynthesis 
(Ueda et al. 2009). Inhibition of nucleotide biosynthesis might block production of modified 
nucleotides acting as signal molecules for biofilm formation, such as c-di-GMP, and stimulate their 
degradation and recycling in nucleotide triphosphate biosynthesis for DNA and RNA production. 
Another possibility might be that an even partial inhibition of nucleotide biosynthesis, such as 
observed at sulfathiazole or fluorouracil concentrations not affecting bacterial growth, might result 
in shortage of deoxyribonucleotides for DNA replication. The bacterial cell may then react by 
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abolishing “non essential” DNA synthesis, such as production of extracellular DNA. Indeed, 
extracellular DNA is an essential component of the biofilm matrix in both Gram positive and Gram 
negative bacteria (Allesen-Holm et al. 2006; Guiton et al. 2009) and treatment with DNase can 
prevent biofilm formation (Whitchurch et al. 2002), a fact which suggests exploitable weaknesses in 
the biofilm matrix. While in some instances eDNA originates from cell lysis (Ando et al. 2006, 
Vilain et al. 2009), in P. aeruginosa and other pathogenic species eDNA release is mediated by 
release of DNA-containing membrane vesicles in response to QS and possibly other cell signalling 
mechanisms (Muto and Goto 1986; Kadurugamuwa and Beveridge 1995; Allesen-Holm et al. 
2006), thus representing an important biofilm related cell process.   
 
Removal of bacterial biofilms by promoting their dispersal 
 Biofilm dispersal can occur as a consequence of mechanical breakage of biofilms due to 
flow or shear stresses. Often, however, dispersal is induced by the biofilm itself in response to 
environmental cues, such as changes in nutrient availability (Sauer et al. 2004; Gjermansen et al. 
2005), fluctuation in local oxygen concentrations (Thormann et al. 2005), or increase in nitric oxide 
(Barraud et al. 2006). Biofilm dispersal is a naturally occurring process which may represent a 
mechanism to escape starvation or other negative environmental conditions within a biofilm, 
allowing bacterial cells the opportunity to migrate to a more favourable environment. In order to 
promote their dispersal, biofilm cells need to produce enzymes able to degrade the EPS matrix that 
surrounds them. To do this a wide variety of EPS-degrading enzymes are used. P. aeruginosa 
secretes alginate lyase in (Boyd and Chakrabarty 1994), whereas the oral pathogen Aggregatibacter 
actinomycetemcomitans (Kaplan et al. 2003) uses Dispersin B, a protein that specifically hydrolyzes 
the glycosidic linkages of poly--1, 6-N-acetylglucosamine (PNAG), an EPS that functions as an 
important biofilm determinant in both Gram negative and Gram positive microorganisms (Cramton 
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et al. 1999; Wang et al. 2004b). Cellular signals leading to biofilm dispersal are tightly 
interconnected with regulatory signals controlling biofilm formation: for instance, in S. aureus, 
production of extracellular serine proteases required for biofilm dispersal is controlled by the agr 
QS system (Boles and Horswill 2008). Likewise, biofilm dispersal in Xanthomonas campestris can 
be triggered by addition of Diffusible Signal Factor (DSF) that, as mentioned above, acts as a 
diffusible QS signal (Dow et al. 2003; Wang et al. 2004a). DSF triggers expression of the manA 
gene, encoding endo--1,4-mannanase, which results in EPS degradation and biofilm dispersal 
(Dow et al. 2003). It has recently been reported that a monounsaturated fatty acid produced by P. 
aeruginosa, cis-2-decenoic acid, can induce cell detachment from biofilms; interestingly, cis-2-
decenoic acid displays biofilm-dispersing effects on both Gram positive and Gram negative 
bacteria, suggesting that monounsaturated fatty acids, unlike other autoinducers, might act as 
“broad spectrum” signal molecules (Davies and Marques 2009). The enzyme lysine oxidase has 
recently been implicated in the dispersal of biofilms in a number of Gram negative bacteria. This 
enzyme has been shown to mediate cell death due to the production of hydrogen peroxide. Such cell 
death is connected with the emergence of a phenotypically diverse dispersal population (Mai-
Prochnow et al. 2008). Thus the mechanisms by which dispersal is mediated are numerous, 
complex and not fully characterised. One common theme is that dispersal causing compounds are 
often active across the species barrier. For example, extracellular polysaccharides secreted by P 
aeruginosa exhibited dispersal activity against staphylococcal biofilms (Qin et al. 2009). 
 Signal molecules which inhibit biofilm formation can also stimulate biofilm dispersal. This 
is the case for c-di-GMP, which not only influences biofilm formation, but also affects the extent of 
biofilm detachment (Morgan et al. 2006; Thormann et al. 2006). In P. aeruginosa, it has been 
shown that treatment of biofilm-growing cells with toxic compounds, such as heavy metals, results 
in detachment of biofilm cells, probably a defence response aimed at mobilizing bacterial cells. This 
process requires the environmental sensor BdlA, which can trigger c-di-GMP degradation, in turn 
resulting in the breakdown of the biofilm (Morgan et al. 2006).  It was also observed that increased 
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levels of nitric oxide (NO) can induce dispersal (Barraud et al. 2006) through stimulation of c-di-
GMP phosphodiesterases activity (Barraud et al. 2009). Thus, inhibitors of c-di-GMP biosynthesis 
might have the potential to promote dispersal of mature biofilm in addition to preventing its 
formation.  
  As already mentioned, the enzyme Dispersin B, in addition to promoting self-dispersal in A. 
actinomycetemcomitans biofilms by enzymatic degradation of the EPS poly-N-acetylglucosamine 
(PNAG), can prevent biofilm formation and trigger biofilm detachment in any PNAG-producing 
bacterial species. Exposure to Dispersin B in the presence of antibiotics (Donelli et al. 2007; Izano 
et al. 2007) or disinfectants such as Triclosan results in synergistic biofilm removal and bacterial 
killing (Darouiche et al. 2009). Unfortunately, combination of Dispersin B or other EPS-degrading 
enzymes with antimicrobials can only find limited use for the treatment of biofilm-mediated 
systemic infections, due to the immunog nic properties of bacterial enzymes. Induction of the 
immune response in the host, with production of antibodies targeting EPS-degrading enzymes, 
would prevent the enzymes from reaching their targets (i.e., infection-causing biofilms) and block 
their effects. Dispersin B in combination with Triclosan is now marketed in gel preparations for 
treatment of wound and skin infections and for disinfection of medical devices, suggesting that 
combinations of antimicrobials and EPS-degrading enzymes can represent a powerful tool for 
biofilm eradication in these settings. 
 
Screening for biofilm dispersal compounds 
Screening for natural compounds that inhibit biofilm formation could be focussed on 
organisms living in an environment where biofilms are common, such as the marine environment, 
the most biologically diverse habitat on the planet. Because many marine creatures are not fouled, 
they must have developed strategies against unwanted micro and macro fouling, either directly or 
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indirectly via symbiotic interactions with microorganisms. Indeed, marine algae, as well as marine 
invertebrates such as sponges, nudibranchs and tunicates, are the source of a large number of 
bioactive compounds, many of which probably function as a defence mechanism against predators 
(Carté and Faulkner, 1986; Paul et al. 1990) and against colonization by bacterial pathogens (James 
et al. 1996). A striking example of compounds which directly inhibit biofilms are the furanones, 
initially isolated from  the marine alga Delisea pulchra (Hentzer et al. 2002) a successful case study 
which supports further investigation of marine organisms as a source of biofilm inhibitors. 
Screening for natural products able to promote biofilm dispersal has led to the identification of 
inhibitors of AHL-based QS, such as bromoageliferin and oroidin (Huigens et al. 2008; Richards et 
al. 2008) produced by marine organisms, that, in addition to preventing biofilm formation, can 
trigger biofilm detachment in Gram negative bacteria. Interestingly, a 2-aminobenzimidazole 
derivative of oroidine is able to disperse biofilm in both Gram positive and Gram negative bacteria, 
and its mode of action involves chelation of zinc ions (Rogers et al. 2009), suggesting that zinc 
might play a role in stabilization of mature biofilms. Increasing evidence suggests that many of 
these secondary metabolites are actually synthesized by microbial symbionts of marine organisms 
(König et al. 2006; Burke et al. 2007). Thus, isolation and characterization of novel bacterial 
species belonging to the microflora associated to marine organisms might constitute a promising 
strategy for the identification of novel natural products with antimicrobial and anti-biofilm 
activities. 
 
Concluding remarks 
 Tolerance of bacterial biofilms to antibiotics can lead to failure of antibiotic therapies, thus 
making inhibition and dispersal of biofilms an attractive therapeutic target. Although anti-biofilm 
agents themselves might not kill the bacteria, they can make them more susceptible to conventional 
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antibiotics as well as to the action of the host immune system. The search for biofilm inhibitors 
using either activity- or structure-based screening has led to the identification of a significant 
number of biofilm inhibitors, including already marketed chemicals and compounds of potential 
therapeutic use (Table 1). Implementation of novel target-oriented screening methods (e.g., c-di-
GMP biosynthesis, biofilm dispersal) should yield an even greater number of promising biofilm 
inhibitors that can be used directly or provide the starting material for drug development. In 
addition, discovery of natural compounds with anti-biofilm activity and characterization of their 
metabolic pathways can pave the way for functional meta-genomics-based studies of bacteria 
producing bioactive compounds. A chemotherapeutic approach combining conventional antibiotics 
and molecules with anti-biofilm activity could form the basis of future clinical protocols against 
biofilm-mediated infections. 
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Table 1. List of selected biofilm inhibitors. 
Compound 
Mechanism of biofilm 
inhibition 
Other reported 
biological effects 
Identification References 
Furanones and 
structural 
analogues  
AHL binding by LasR 
protein 
Antimicrobial 
activity on Gram 
positive bacteria 
Activity-based 
screening 
Hentzer et al. 2002; 
Müh et al. 2006 
Azithromycin 
Inhibition of LasR-
dependent gene expression  
Protein synthesis 
inhibitor 
Evaluation of 
antimicrobial 
activity 
Nalca et al. 2006; 
Hoffmann et al. 2007  
4-NPO 
Inhibition of LasR-
dependent gene expression 
None 
Activity-based 
screening 
Rasmussen et al. 2005 
Hamamelitannin 
RIP analogue (RNAIII 
inhibitor) 
None 
Structure-based 
virtual screening 
Kiran et al. 2008 
Sulfathiazole  
Inhibition of c-di-GMP 
biosynthesis 
Inhibition of 
tetrahydrofolate 
biosynthesis 
Activity-based 
screening  
Antoniani et al. 2010 
Fluorouracil 
Inhibition of AriR biofilm 
regulatory protein 
Inhibition of 
nucleotide 
biosynthesis 
Activity-based 
screening 
Attila et al. 2009 
Dispersin B 
Enzymatic degradation of 
biofilm matrix 
None 
Genetic screening 
for mutants in 
biofilm formation 
Kaplan et al. 2003 
DNase I 
Enzymatic degradation of 
biofilm matrix 
Degradation of 
DNA 
Target-oriented 
direct testing  
Whitchurch et al. 2002 
cis-2-decenoic 
acid 
signalling molecule None 
Activity-based 
screening  
Davies and Marques 
2009 
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Figure legends 
 
Figure 1. Schematic representation of biofilm development and transition from and to the 
planktonic lifestyle. The main events linked to the different stages of biofilm development are 
indicated. Examples of chemical compounds affecting biofilm-related cell processes are shown. 
Inhibition is represented by the blunt arrow; stimulatory effects are represented by a pointed arrow. 
See text for further details. (Abbreviations: QS= quorum sensing; EPS= extracellular 
polysaccharides) 
Figure 2. Summary of regulatory processes controlling biofilm formation, maintenance and 
dispersal in the Gram negative bacterium P. aeruginosa (Figure 2A) and in the Gram positive 
bacterium S. aureus (Figure 2B). Figure 2A: acyl-homoserine lactone autoinducers (AHLs; 
represented by the diamond and the squiggly line) can diffuse through the cell membranes. AHLs 
accumulation and binding to the LasR protein trigger activation of biofilm- and virulence-related 
genes (above in the figure). Production of adhesion factors can be controlled by intracellular 
accumulation of c-di-GMP, which can act as allosteric activator of EPS biosynthesis or as co-factor 
in gene expression regulation (below in the figure). Inhibitors of the two regulatory processes are 
shown. Figure 2B: the AgrD oligopeptide (the QS autoinducer) is synthesized as a linear peptide 
modified and exported by the AgrB protein. Its accumulation leads to interaction with the AgrC 
sensor protein, which phosphorylates the AgrA response regulator, leading to transcription 
activation of virulence-related genes. Full activation of the QS system requires autophosphorylation 
of TRAP, a sensor protein which responds to RAP, another oligopeptide autoinducer. 
Autophosphorylation of TRAP is inhibited by the RIP protein and can be blocked by the QS 
inhibitor Hamamelitannin. Figure 2B was adapted from (Horswill et al. 2007). 
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